In addition, another report indicates that p16/MCM2 dual staining has higher sensitivity than the cytology test and better specificity than the HPV test for SIL lesions, suggesting that p16/MCM2 might be used as an innovative biomarker for CC screening [37]. The gene discussed is MCM2; the disease is squamous cell intraepithelial neoplasia.